20/20 BioLabs
Pre-clinical20/20 BioLabs (formerly 2020 GeneSystems) develops and commercializes cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our advanced diagnostics leverage machine learning algorithms built on extensive real-world data, offering exceptional accuracy and convenience for individuals and providers.
About
20/20 BioLabs (formerly 2020 GeneSystems) develops and commercializes cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our advanced diagnostics leverage machine learning algorithms built on extensive real-world data, offering exceptional accuracy and convenience for individuals and providers.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile